[{"Assets_0_Q2_USD":5851000000.0,"EarningsPerShareBasic_1_Q2_USD":1.42,"EarningsPerShareBasic_2_Q2_USD":2.84,"EarningsPerShareDiluted_1_Q2_USD":1.41,"EarningsPerShareDiluted_2_Q2_USD":2.82,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":550000000.0,"NetIncomeLoss_1_Q2_USD":209000000.0,"NetIncomeLoss_2_Q2_USD":417000000.0,"StockholdersEquity_0_Q2_USD":3257000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":148000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":148000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":147000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":147000000.0,"Ticker":"ILMN","CIK":"1110803","name":"ILLUMINA INC","OfficialName":"Illumina Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"53766364980.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"SP500","filed":"20180731"}]